Burrell Terry-Ann Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$16.81M

Insider Activity of Burrell Terry-Ann

Biography of Burrell Terry-Ann

No biography is available at this moment.

2024-04-01SaleBeam Therapeutics Inc.
BEAM
Chief Financial Officer
5,446
0.0077%
$32.12$174,926-23.45%
2023-07-13SaleRecursion Pharmaceuticals, Inc.
RXRX
director
8,275
0.0044%
$12.59$104,143-28.27%
2023-07-12SaleRecursion Pharmaceuticals, Inc.
RXRX
director
108,725
0.0565%
$12.03$1.31M-26.12%
2023-04-04SaleBeam Therapeutics Inc.
BEAM
Chief Financial Officer
2,186
0.0028%
$29.09$63,598-0.47%
2023-04-03SaleBeam Therapeutics Inc.
BEAM
Chief Financial Officer
2,454
0.0033%
$30.31$74,381-2.19%
2023-01-27SaleBeam Therapeutics Inc.
BEAM
Chief Financial Officer
36,152
0.0719%
$45.08$1.63M-34.26%
2023-01-24SaleBeam Therapeutics Inc.
BEAM
Chief Financial Officer
14,810
0.0294%
$45.01$666,657-33.06%
2023-01-18SaleBeam Therapeutics Inc.
BEAM
Chief Financial Officer
47,195
0.094%
$45.14$2.13M-32.31%
2022-03-31SaleBeam Therapeutics Inc.
BEAM
CFO
1,787
0.0047%
$59.11$105,630-23.04%
2021-06-30SaleBeam Therapeutics Inc.
BEAM
CFO
30,000
0.1615%
$122.00$3.66M-41.87%
2021-06-28SaleBeam Therapeutics Inc.
BEAM
CFO
45,000
0.2138%
$107.69$4.85M-30.64%
2021-01-04SaleBeam Therapeutics Inc.
BEAM
CFO
25,000
0.0902%
$81.78$2.04M+7.88%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.